M8 Pharmaceuticals, an Acino company (“M8”), today announces the signature of an exclusive licensing and distribution agreement with LG Chem...
The agreement focuses on the distribution of Allecra’s novel antibiotic drug EXBLIFEP® (cefepime/enmetazobactam) within the Republic of South Africa and...
M8 Pharmaceuticals, an Acino company (‘M8’) announces that the company has signed an exclusive licensing agreement with Supernus Pharmaceuticals, Inc....
Joel Barlan has been appointed as Head of the LATAM region. Mexico City will now serve as a regional hub...
M8 Pharmaceuticals, an Acino company (“M8”) and SERB Pharmaceuticals (“SERB”), a global specialty pharmaceutical company, are collaborating to bring an...
The agreement focuses on the distribution of orphan drugs developed for patients with conditions such as rheumatoid arthritis, cryopyrin-associated periodic...
With nearly 300 new employees on board, Acino will enhance its presence in Latin America and strengthen its business through...
Over 300 M8 employees, product portfolio and pipeline to enhance Acino’s footprint and strategic position in key Latin American markets....
Report reflects Acino’s commitment to Environmental, Social, and Governance sustainability including goal of reaching carbon neutrality by 2050. ZURICH, Switzerland,...